# A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia

> **NCT01651273** · PHASE1 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 97 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** BMS-852927
- **DRUG:** BMS-852927
- **DRUG:** BMS-852927
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01651273
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2013-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651273, "A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01651273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*